A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family
Primary Purpose
Influenza
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
sanitation and personal hygiene
Sponsored by
About this trial
This is an interventional prevention trial for Influenza
Eligibility Criteria
Inclusion Criteria:
- Family members of an index case with influenza-like illness (ILI) during the first two days of his illness.
- No limitations will be given regarding the number of family members.
Exclusion Criteria:
- Presence of another household member with ILI during the previous two weeks.
Sites / Locations
Outcomes
Primary Outcome Measures
secondary infection of influenza within the family
Secondary Outcome Measures
compliance of non-pharmaceutical interventions
Full Information
NCT ID
NCT00410176
First Posted
December 11, 2006
Last Updated
December 11, 2006
Sponsor
Ministry of Health, Israel
1. Study Identification
Unique Protocol Identification Number
NCT00410176
Brief Title
A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family
Study Type
Interventional
2. Study Status
Record Verification Date
December 2006
Overall Recruitment Status
Unknown status
Study Start Date
January 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Ministry of Health, Israel
4. Oversight
5. Study Description
Brief Summary
The proposed study will evaluate whether the use of non-pharmaceutical methods, such as surgical masks, isolation of patients and personal hygiene, are acceptable and effective in preventing the spread of influenza within the family.This will be achieved by conducting a randomized, controlled, unblinded, clinical trial. Family members of an index case with influenza like illness, will be randomly allocated to two groups. In the intervention group, family members will receive comprehensive guidance about sanitation and hygiene, as well as surgical masks to wear whenever in close contact (3 feet / 1 meter) with the index case. In addition, they will be asked to isolate the index case as much as possible. In the control group, family members will receive only standard guidance about sanitation and hygiene relevant for reducing the transmission of influenza. The primary end-point of the study will be secondary infection of influenza of at least one of the family members in order to asses the efficacy of the interventions. In addition, the compliance to those interventions will be evaluated.
The study hypothesis is that use of non-pharmaceutical methods will be acceptable and will reduce the secondary infection rate among them by 50%.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Influenza
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
sanitation and personal hygiene
Primary Outcome Measure Information:
Title
secondary infection of influenza within the family
Secondary Outcome Measure Information:
Title
compliance of non-pharmaceutical interventions
10. Eligibility
Sex
All
Eligibility Criteria
Inclusion Criteria:
Family members of an index case with influenza-like illness (ILI) during the first two days of his illness.
No limitations will be given regarding the number of family members.
Exclusion Criteria:
Presence of another household member with ILI during the previous two weeks.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Manfred S Green, PhD, M.D
Phone
972-3-7371500
Ext
203
Email
m.green@icdc.health.gov.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Manfred S Green, PhD, M.D
Organizational Affiliation
ICDC
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family
We'll reach out to this number within 24 hrs